ATE362943T1 - Zusammensetzungen enthaltend chitosan in der form von nanofasern - Google Patents

Zusammensetzungen enthaltend chitosan in der form von nanofasern

Info

Publication number
ATE362943T1
ATE362943T1 AT02792233T AT02792233T ATE362943T1 AT E362943 T1 ATE362943 T1 AT E362943T1 AT 02792233 T AT02792233 T AT 02792233T AT 02792233 T AT02792233 T AT 02792233T AT E362943 T1 ATE362943 T1 AT E362943T1
Authority
AT
Austria
Prior art keywords
compositions
care
nanofibers
compositions containing
containing chitosan
Prior art date
Application number
AT02792233T
Other languages
English (en)
Inventor
Gordon Robert Davison
Axel Konig
Clyde Gibbons
Mark Brian Ripley
Neil Archibald Macgilp
Georgina Lyndsey Claire Milich
Emma Louise Pretswell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE362943T1 publication Critical patent/ATE362943T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/027—Fibers; Fibrils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02—Preparations for deodorising, bleaching or disinfecting dentures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Materials For Medical Uses (AREA)
AT02792233T 2001-11-09 2002-11-08 Zusammensetzungen enthaltend chitosan in der form von nanofasern ATE362943T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0126923.2A GB0126923D0 (en) 2001-11-09 2001-11-09 Chitosan compositions

Publications (1)

Publication Number Publication Date
ATE362943T1 true ATE362943T1 (de) 2007-06-15

Family

ID=9925463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02792233T ATE362943T1 (de) 2001-11-09 2002-11-08 Zusammensetzungen enthaltend chitosan in der form von nanofasern

Country Status (9)

Country Link
US (1) US6638918B2 (de)
EP (1) EP1442066B1 (de)
JP (1) JP2005509059A (de)
AT (1) ATE362943T1 (de)
CA (1) CA2466654C (de)
DE (1) DE60220306T2 (de)
ES (1) ES2287347T3 (de)
GB (1) GB0126923D0 (de)
WO (1) WO2003042251A1 (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
US6740752B2 (en) * 2000-05-12 2004-05-25 The Procter & Gamble Company Process for preparing chitosan particles
US6972010B2 (en) * 2001-04-17 2005-12-06 The Procter & Gamble Company Absorbent article comprising an agent able to convey a perception to the wearer, without the need to create the external condition perceived
KR20040058325A (ko) * 2001-11-26 2004-07-03 유겐가이샤 오까다 기껜 소취제 및 이를 함유하는 세발 화장료
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
EP1384404A1 (de) * 2002-07-23 2004-01-28 The Procter & Gamble Company Haarpflegemittel
US8409618B2 (en) 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
CA2534483A1 (en) * 2003-09-19 2005-03-31 Hill's Pet Nutrition, Inc. Composition and method for treating bezoar and trichobezoar
US7794737B2 (en) * 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7413550B2 (en) 2003-10-16 2008-08-19 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7837663B2 (en) 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7488520B2 (en) 2003-10-16 2009-02-10 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
AU2004287281A1 (en) * 2003-11-11 2005-05-19 Veckis Industries Ltd. Disinfecting composition and methods of making and using same
ES2313100T3 (es) * 2003-12-23 2009-03-01 Unilever N.V. Barrera comestible.
US20050142965A1 (en) * 2003-12-29 2005-06-30 Kimberly-Clark Worldwide, Inc. Surface charge manipulation for improved fluid intake rates of absorbent composites
US20050196497A1 (en) * 2004-03-03 2005-09-08 Kraft Foods Holdings, Inc. Antimicrobial effect of chitosan in beverages
WO2005087280A1 (en) * 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
US7163579B2 (en) * 2004-04-14 2007-01-16 H.B. Fuller Licensing & Financing Inc. Method of making water resistant corrugated boards
WO2005107710A2 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20050283004A1 (en) 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
CA2568813C (en) * 2004-06-21 2013-12-17 Basf Aktiengesellschaft Aqueous preparations comprising a water-soluble or water-dispersible copolymer that contains at least one imidazole or amine containing monomer
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
US20090076168A1 (en) * 2005-03-04 2009-03-19 Tien Canh Le Amine-based and imine-based polymers, uses and preparation thereof
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US8308075B2 (en) 2005-04-19 2012-11-13 Kamterter Products, Llc Systems for the control and use of fluids and particles
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
DE102005048776A1 (de) * 2005-10-07 2007-04-12 Beiersdorf Ag Desodorierende Reinigungszubereitung
ITRM20050585A1 (it) * 2005-11-23 2007-05-24 Mavi Sud S R L Nanofibrille di chitina spray-dried, metodo di produzione ed usi.
FR2894809B1 (fr) * 2005-12-15 2008-03-21 Oreal Composition cosmetique comprenant une dispersion aqueuse de particules colloidales de charge minerale et des fibres
US7977103B2 (en) 2006-04-20 2011-07-12 Kimberly-Clark Worldwide, Inc. Method for detecting the onset of ovulation
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
US20080072494A1 (en) * 2006-09-07 2008-03-27 Stoner Richard J Micronutrient elicitor for treating nematodes in field crops
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
WO2008042944A2 (en) * 2006-10-05 2008-04-10 The Trustees Of Columbia University In The City Of New York Non-irritating oral care formulations
US20080114096A1 (en) * 2006-11-09 2008-05-15 Hydromer, Inc. Lubricious biopolymeric network compositions and methods of making same
US8163886B2 (en) * 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
EP1958639A1 (de) 2007-02-14 2008-08-20 Polichem S.A. Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel
ES2552842T3 (es) 2007-02-19 2015-12-02 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
WO2008135957A2 (en) 2007-05-07 2008-11-13 Koninklijke Philips Electronics N.V. A method for cleaning dental plaque from teeth using an adherent peelable gel
CZ2007716A3 (cs) 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
TW200928022A (en) * 2007-12-31 2009-07-01 Acelon Chem & Fiber Corp Manufacturing method for natural cellulose fiber with increased mildew-proof, antibacterial and deodorizing functions
TWI441641B (zh) * 2007-12-31 2014-06-21 Preparation of chitosan with ultra - fine nano - modification
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US7943597B2 (en) * 2008-04-08 2011-05-17 Cypress Pharmaceutical, Inc. Phosphate-binding chitosan and uses thereof
WO2009151514A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
EP2153836A1 (de) 2008-08-04 2010-02-17 Polichem S.A. Filmbildende flüssige Formulierungen zur Wirkstofffreisetzung im Haar und auf der Kopfhaut
EP2116237A1 (de) 2008-08-05 2009-11-11 Polichem SA Zusammensetzungen enthaltend Chitosan und Dicarboxysäure zur Behandlung von Rosacea
JP4333966B1 (ja) * 2008-08-29 2009-09-16 株式会社データアクション 入浴剤及び浴湯
US20100190963A1 (en) * 2008-12-16 2010-07-29 Millipore Corporation Stirred Tank Reactor And Method
EP2266546A1 (de) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
MY157460A (en) * 2010-03-22 2016-06-15 Water Security Corp Filter comprising a halogen release system and chitosan
US9309435B2 (en) 2010-03-29 2016-04-12 The Clorox Company Precursor polyelectrolyte complexes compositions comprising oxidants
US20110236582A1 (en) * 2010-03-29 2011-09-29 Scheuing David R Polyelectrolyte Complexes
US9474269B2 (en) 2010-03-29 2016-10-25 The Clorox Company Aqueous compositions comprising associative polyelectrolyte complexes (PEC)
JP2013523898A (ja) 2010-04-15 2013-06-17 マリン ポリマー テクノロジーズ，インコーポレーテッド ポリ−ｎ−アセチルグルコサミンナノファイバーの抗菌性の適用
WO2011146394A1 (en) 2010-05-17 2011-11-24 Millipore Corporation Stimulus responsive polymers for the purification of biomolecules
JP5974407B2 (ja) * 2010-09-16 2016-08-23 国立大学法人鳥取大学 キチンナノファイバーまたはキトサンナノファイバーを含む化粧料、入浴剤および医薬組成物
EP2635261B1 (de) * 2010-11-06 2019-10-23 Marine Polymer Technologies, Inc. Zusammensetzungen und verfahren für nanopolymerbasierte freisetzung von nukleinsäuren
SG192256A1 (en) * 2011-02-18 2013-09-30 Gaba Int Holding Ag Mouthrinse composition
SG192257A1 (en) * 2011-02-18 2013-09-30 Gaba Int Holding Ag Dentifrice composition
WO2012119155A1 (en) * 2011-03-03 2012-09-07 American Dental Association Foundation Antimicrobial compositions for tooth fluoridation and remineralization
CN107362171A (zh) 2011-04-15 2017-11-21 海洋聚合物技术公司 用聚‑n‑乙酰基葡糖胺纳米纤维治疗疾病
CN102504352B (zh) * 2011-11-03 2013-12-25 华南理工大学 一种羧甲基壳寡糖季铵盐/累托石纳米复合材料及其制备方法与应用
TWI419701B (zh) * 2011-11-08 2013-12-21 包覆生長因子之多醣體微粒子
US20140186273A1 (en) * 2012-12-27 2014-07-03 University Of Southern California Chitosan -Amelogenin Hydrogel for In Situ Enamel Growth
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
PE20160473A1 (es) 2013-05-29 2016-05-22 Aguas De Manizales S A E S P Composiciones para tratamiento de aguas y metodos para uso de las mismas
CN103319750B (zh) * 2013-06-13 2016-10-05 华南理工大学 一种羧甲基壳聚糖季铵盐/改性磷酸锆纳米复合材料
DE102013211519A1 (de) * 2013-06-19 2015-01-08 Henkel Ag & Co. Kgaa Mund- und Zahnpflege- und -reinigungsmittel zur Verringerung der Wiederanfärbung von Zähnen
US9907738B2 (en) 2013-06-27 2018-03-06 The Procter & Gamble Company Personal care compositions and articles
EP3060310A1 (de) 2013-10-23 2016-08-31 Unilever PLC Antitranspirantzusammensetzung
US8975220B1 (en) 2014-08-11 2015-03-10 The Clorox Company Hypohalite compositions comprising a cationic polymer
FR3035798B1 (fr) 2015-05-07 2017-04-28 Ifp Energies Now Particules spheroidales d'alumine de resistance mecanique amelioree ayant un diametre median macroporeux compris entre 0,05 et 30 μm.
CL2015001254A1 (es) * 2015-05-08 2015-09-11 Cyra Consultora Limitada Composición quelante de arsénico.
CL2015001532A1 (es) * 2015-06-05 2015-12-28 Fundación Copec Universidad Católica Nanofibras de quitosano contenedoras de compuestos bioactivos
US9962465B2 (en) 2015-07-07 2018-05-08 University Of Southern California Amelogenin-chitosan hydrogel for dentin hypersensitivity
KR102130319B1 (ko) * 2015-08-19 2020-07-09 (주) 에이치엔에이파마켐 천연 유래 다당류를 이용한 마이크로 섬유의 제조 방법 및 이에 의해 제조된 마이크로 섬유를 포함하는 화장료 조성물
JP6577332B2 (ja) * 2015-10-29 2019-09-18 旭化成株式会社 抗菌性能に優れた抗菌性合成繊維布帛
CA3001437A1 (en) * 2015-11-09 2017-05-18 Unilever Plc Anti-perspirant composition
CN110022846A (zh) * 2016-09-30 2019-07-16 欧莱雅 含有基于硫醇的化合物的美发组合物和用于清洁和处理头发的方法
CZ2016688A3 (cs) * 2016-11-03 2017-12-20 Nano Medical s.r.o. Způsob vytvoření nanovlákenné vrstvy a textilní kompozit obsahující nanovlákennou vrstvu vytvořenou tímto způsobem
WO2018099931A1 (en) 2016-12-01 2018-06-07 Unilever Plc Anti-perspirant composition comprising chitosan
JP6896267B2 (ja) * 2017-04-06 2021-06-30 国立研究開発法人産業技術総合研究所 多孔質体及びその製造方法
US20210052472A1 (en) 2017-12-29 2021-02-25 Gaba International Holding Gmbh Dentifrice Composition
JP7083131B2 (ja) * 2018-01-25 2022-06-10 国立大学法人鳥取大学 発毛および育毛促進剤
JP7234007B2 (ja) * 2019-03-29 2023-03-07 株式会社ナリス化粧品 皮膚外用剤
CN111892667B (zh) * 2019-04-30 2024-02-20 苏州大学 含氟化合物修饰的阳离子聚合物在制备医疗美容及保健品中的应用
GB201909271D0 (en) * 2019-06-27 2019-08-14 Univ Cork Method for producing porous graphene or porous graphtic carbon
KR102231747B1 (ko) * 2019-10-16 2021-03-24 대경대학교 산학협력단 보색샴푸 조성물 및 이의 제조방법
KR102503193B1 (ko) * 2019-11-04 2023-02-23 주식회사 엔도비전 버섯 또는 진균 유래 키토산, 또는 그 유도체를 이용한 하이드로겔 및 그 제조방법
CN111213632B (zh) * 2019-11-19 2022-03-01 长春中医药大学 动物药环氧树脂标本制作方法
KR102541470B1 (ko) * 2020-11-23 2023-06-07 주식회사 유에이치에스 버섯 유래 키토산을 이용한 가축 및 반려동물용 음수첨가제 및 이의 제조방법
CN112675096B (zh) * 2021-01-22 2022-11-08 上海加新生物科技有限公司 一种抑菌杀菌植物复合组合物及其制备方法
KR102661511B1 (ko) * 2021-10-20 2024-04-26 서울대학교산학협력단 키토산 담체 합성 장치 및 방법
CN114874039A (zh) * 2022-05-18 2022-08-09 普洱学院 一种咖啡果皮有机肥料及其制备方法
WO2024003790A1 (en) * 2022-06-29 2024-01-04 11584022 Canada Inc. Biopolymer formulations for drug delivery
CN115475257A (zh) * 2022-08-29 2022-12-16 广州市一杰医药科技有限公司 一种医用超声耦合剂及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262827A (ja) * 1985-09-12 1987-03-19 Fuji Boseki Kk 超微小球状キトサンの製造方法
JPH02135134A (ja) 1988-11-16 1990-05-24 Katokichi:Kk 水・アルコール混合液分離用膜
JPH09249541A (ja) 1996-03-15 1997-09-22 Fudo Kosan:Kk 歯磨剤
WO2000047177A1 (de) 1999-02-09 2000-08-17 Cognis Deutschland Gmbh Verwendung von nanoskaligen chitosanen und/oder chitosanderivaten
DE19911041A1 (de) * 1999-03-12 2000-09-14 Henkel Kgaa Mit Nanopartikel-Dispersionen ausgerüstete, flexible und saugfähige Träger zur Behandlung der Haut
WO2001010421A1 (en) 1999-08-06 2001-02-15 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
PL189890B1 (pl) 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
FR2799647B1 (fr) 1999-10-15 2001-12-07 Oreal Composition sous forme d'emulsion eau-dans-huile, contenant des fibres, et son utilisation dans le domaine cosmetique
DE19952073A1 (de) 1999-10-29 2001-07-12 Cognis Deutschland Gmbh Verfahren zur Herstellung von nanopartikulären Chitosanen oder Chitosan-Derivaten
DE10014529A1 (de) * 2000-03-23 2001-09-27 Cognis Deutschland Gmbh Desodorierende Zubereitungen mit nanoskaligen Chitosanen und/oder Chitosanderivaten
PL340132A1 (en) 2000-05-12 2001-11-19 Procter & Gamble Method of obtaining modified microcrystalline chitosamine
EP1243688A1 (de) 2001-03-22 2002-09-25 Cognis Iberia, S.L. Verwendung von Chitosan-Nanopartikeln

Also Published As

Publication number Publication date
CA2466654C (en) 2009-03-31
GB0126923D0 (en) 2002-01-02
JP2005509059A (ja) 2005-04-07
EP1442066A1 (de) 2004-08-04
US20030104020A1 (en) 2003-06-05
ES2287347T3 (es) 2007-12-16
EP1442066B1 (de) 2007-05-23
US6638918B2 (en) 2003-10-28
CA2466654A1 (en) 2003-05-22
DE60220306T2 (de) 2008-01-17
WO2003042251A1 (en) 2003-05-22
DE60220306D1 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
ATE362943T1 (de) Zusammensetzungen enthaltend chitosan in der form von nanofasern
RU2000119159A (ru) Микропористые пленки, включающие флокированные волокна
CN110062616A (zh) 皮肤附着型贴片
ATE299022T1 (de) Verwendung von cyclopamine zur herstellung eines arzneimittels zur behandlung von psoriasis
DK1438081T3 (da) Medicinsk transplantatanordning med mesh mönstret struktur
DE60138817D1 (de) Biologisch aktives material
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
ES2072563T3 (es) Composicion para el tratamiento cosmetico y/o farmaceutico de las capas superiores de la epidermis por aplicacion topica sobre la piel y procedimiento de preparacion correspondiente.
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
US20040062798A1 (en) Exothermic article and the use thereof in whitening teeth
US20040163649A1 (en) Disposable face mask with skin-care face-contacting layer
KR20040085646A (ko) 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법
DE69516110D1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
DE60128911D1 (de) Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen
DE50107692D1 (de) Verwendung von selenithältigen wässerigen lösungen zur herstellung eines medikaments zur behandlung viraler erkrankungen und pigmentflecken
CN2728488Y (zh) 甲壳素面膜
CN104510643A (zh) 一种睡莲根草本提取物保湿洗手液
KR20040040216A (ko) 피부보습 및 살균력을 갖는 미용팩
ATE220548T1 (de) Verwendung von oxazolidinonen zur herstellung eines arzneimittels zur transdermalen darreichung
KR200308368Y1 (ko) 자연건강 패드
Mustafi et al. Clinical efficacy of a monofilament fibre containing wound debridement product evaluated in multicentre real life study [poster]
Adhikari Study Between Rural and Urban Basic Level Students on Personal Hygiene
BR0112874A (pt) Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties